Celecoxib selectively inhibits the COX-2 enzyme, sparing COX-1, which helps protect the stomach lining and reduces the risk of gastrointestinal ulcers compared with non-selective NSAIDs.
Concurrent use may increase the risk of gastrointestinal bleeding; low-dose aspirin should only be combined under medical supervision, with gastro-protective strategies considered.
Most patients experience pain relief within 1-2 hours after a 200 mg dose, making it a common choice for primary dysmenorrhea.
No specific foods must be avoided, but taking the tablet with a meal can lessen stomach discomfort.
Celecoxib can raise blood pressure; patients with hypertension should have their blood pressure monitored regularly and use the lowest effective dose.
Take the missed dose as soon as you remember, unless it’s nearly time for the next scheduled dose; do not double the dose.
In individuals with pre-existing kidney disease or those taking diuretics, celecoxib may reduce renal blood flow; regular renal function monitoring is advised.
Short-term use carries a lower cardiovascular risk than chronic therapy, but patients with a history of heart disease should discuss alternatives with their doctor.
Keep them in their original container at room temperature, away from excess heat or moisture, and in your carry-on luggage to avoid loss or temperature extremes.
Yes; generic celecoxib contains the same active ingredient, dosage, and formulation, and must meet the same regulatory standards for safety and efficacy.
Celecoxib is a non-steroidal anti-inflammatory drug (NSAID) that belongs to the cyclo-oxygenase-2 (COX-2) inhibitor class. It is available in pill form and marketed in the United Kingdom under the generic name celecoxib, with strengths of 100 mg and 200 mg. The medication is prescription-only (Rx) and regulated by the Medicines and Healthcare products Regulatory Agency (MHRA).
Celecoxib selectively blocks the COX-2 enzyme, which is responsible for producing prostaglandins that mediate pain, inflammation, and fever. By inhibiting COX-2 while sparing COX-1, celecoxib reduces inflammation and pain without markedly affecting the stomach-protecting prostaglandins generated by COX-1.
Celecoxib is approved by the MHRA for the following indications:
These uses reflect the drug’s ability to control inflammation and alleviate moderate to severe pain in adult patients.
Evidence-Based Off-Label Uses
Investigational Uses Under Study
Off-label use requires medical supervision and individualized risk assessment.
Major:
Warfarin - concurrent use can increase bleeding risk; close INR monitoring is advised.
Lithium - celecoxib may raise lithium serum levels; monitor for lithium toxicity.
Moderate:
ACE inhibitors, diuretics, and beta-blockers - additive effect on blood pressure; monitor blood pressure and renal function.
Other NSAIDs - combined use elevates gastrointestinal and cardiovascular risk; generally avoided.
These interactions are primarily due to celecoxib’s influence on renal prostaglandin synthesis and hepatic metabolism via CYP2C9.
Standard dosing:
100 mg tablet: Often prescribed for chronic conditions (e.g., osteoarthritis) once daily.
200 mg tablet: Commonly used for acute pain, taken as a single dose or divided into two doses (100 mg each) 12 hours apart.
Special populations:
Renal impairment: Dose reductions are recommended; a healthcare provider may start with 100 mg once daily.
Hepatic impairment: Use the lowest effective dose; monitor liver function tests regularly.
Administration: Swallow the pill whole with a full glass of water; do not crush or chew.
Missed dose: If a dose is missed, take it as soon as remembered unless it is close to the next scheduled dose; do not double up.
Overdose: Symptoms may include nausea, vomiting, abdominal pain, and dizziness. Seek urgent medical care; activated charcoal may be administered in a clinical setting.
Discontinuation: Sudden stopping is generally safe, but for long-term use, a physician may advise tapering to minimise rebound pain.
Patients should contact their healthcare provider if they experience chest pain, shortness of breath, sudden severe headache, or any signs of serious skin reactions.
This article provides educational information about celecoxib and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
